跳至主要内容
临床试验/CTRI/2016/03/006695
CTRI/2016/03/006695已完成2 期

Pharmaceutical development of Shirishavaleha and its Granules prepared with Khanda Sharkara and their comparative efficacy on Tamaka Shwasa(Bronchial Asthma) - SHA SHG

IPGT RA JAMNAGAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Mild persistent cases of Bronchial Asthma withdaytime symptoms 3-6/week and nocturnal symptoms with 3-4/month.
  • Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 weeks.

排除标准

  • Known patients of diabetes,
  • Dyspnoea resulting from cardiac origin, anaemia,
  • Age above 60 years and below 20 years,
  • Patients suffering from tuberculosis, malignancy and other chronic debilitating diseases, HIV positive cases,
  • Pregnant and lactating mothers
  • Patients who depend on regular use of inhalers,
  • Patients suffering with other types of Shwasa explained in AYurveda classics like i.e. Maha, Urdha, Chhinna Shwasa will be excluded from the study.

研究者

发起方
IPGT RA JAMNAGAR

相似试验